Myeloma Other
Chimeric antigen receptor (CAR) T-cell therapy for leukemia
应用嵌合抗原受体T细胞疗法治疗白血病
Cytotoxic T lymphocytes for leukemia and lymphoma
细胞毒性T淋巴细胞治疗白血病和淋巴瘤
Maximizing graft-versus-leukemia in allogeneic transplantation: Role of donor lymphocyte infusions
最大化异基因造血干细胞移植中的移植物抗白血病效应：供者淋巴细胞输注的作用
The genomic landscape of acute lymphoblastic leukemia in children and young adults
儿童和青壮年急性淋巴细胞白血病患者的基因组图谱研究
Clinically defining and managing high-risk pediatric patients with acute lymphocytic leukemia
高危儿童急性淋巴细胞白血病患者的临床界定和管理
Balancing cure and long-term risks in childhood acute lymphoblastic leukemia
儿童急性淋巴细胞白血病患者的治疗与长期风险之间的平衡
Defining minimal residual disease in acute myeloid leukemia: Which platforms are ready for “prime time”?
探查急性髓细胞白血病微小残留病灶：哪种检测平台将进入黄金时期？
Goals for chronic myeloid leukemia TK inhibitor treatment: How little disease is too much?
慢性髓细胞白血病酪氨酸激酶抑制剂治疗目标：小病从来不小
Detection and management of minimal residual disease in acute lymphoblastic leukemia
急性淋巴细胞白血病微小残留病灶的检测和管理策略
Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis
MYD88在淋巴浆细胞淋巴瘤的诊断和发病机制中的作用
Mutations in chronic lymphocytic leukemia, and how they impact therapy choice: Focus on NOTCH1, SF3B1, and TP53
慢性淋巴细胞白血病相关突变及其对治疗选择的影响：集中讨论NOTCH1、SF3B1和TP53
B-cell receptor pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma
B细胞受体信号通路抑制治疗慢性淋巴细胞白血病和淋巴浆细胞淋巴瘤
Intermediate-risk acute myeloid leukemia therapy: Current and future
中危急性髓细胞白血病的治疗：现状与展望
Immunotherapy for acute leukemia
急性白血病的免疫治疗
Epigenetic targeting and personalized approaches for acute myeloid leukemia
急性髓细胞白血病的表观遗传学靶向治疗及个体化治疗策略
Geriatric perspective: How to assess fitness for chemotherapy in older adults with acute myeloid leukemia
老年学评估：如何评估急性髓细胞白血病老年患者化疗的适合性
Treating acute myeloid leukemia in older adults
急性髓细胞白血病老年患者的治疗
Allogeneic transplants in older patients with acute myeloid leukemia
急性髓细胞白血病老年患者的异基因移植治疗
